Glanbia to offload Body & Fit sports nutrition label amid US$50M cost savings program

Glanbia has reached an agreement to sell Body & Fit, its Benelux-based direct-to-consumer e-commerce sports nutrition and supplements business, to an undisclosed buyer. The announcement was included in the company’s newly released half-year 2025 results.

The Irish multinational nutrition company acquired Body & Fit in 2017, integrating its corporate office and distribution warehouse based in the Netherlands and making investments to expand its reach across Europe.

The sale comes as Glanbia reports a resilient first half-year performance, with adjusted earnings per share ahead of expectations, leading to an upgrade in its full-year guidance.

The company’s Performance Nutrition division, which included Body & Fit, saw a revenue decline of 3.8% in the first half of 2025. However, the decline was a more modest 1.5% when excluding the impact of weight loss brand SlimFast (whose sale was announced in February) and Body & Fit.

The divestments were announced amid a multi-year “group-wide transformation program” aimed at driving efficiencies and achieving cost savings of at least US$50 million by 2027.

Half-year developments

Glanbia’s sports nutrition protein powder brand Optimum Nutrition saw a slight revenue decline of 0.5% in Q1. However, performance improved as the period progressed, with a 2% increase in revenue in the second quarter. This growth was driven by a 1.5% rise in sales volume and a 0.5% increase in pricing.

Glanbia acquired Body & Fit in 2017, taking over its head operations in the Netherlands.Glanbia’s strategic updates also included the acquisition of Sweetmix, a Brazil-based nutritional premix and ingredients solutions business, to be integrated into its Health & Nutrition division. The company eyes “continued growth” in the Latin America region.

Meanwhile, Glanbia’s Health & Nutrition and Dairy Nutrition divisions demonstrated strong growth in the period, with revenue increases of 18% and 14.1% respectively. The two divisions were split into standalone segments last November.

The company also announced that Paul Duffy will be appointed company chair on January 1, 2026, succeeding Donard Gaynor, who will retire at the end of 2025. 

Glanbia will host a Capital Markets Day on November 19, 2025, to provide further updates on its medium-term growth agenda.